======= LY96 ======= == Gene Information == * **Official Symbol**: LY96 * **Official Name**: lymphocyte antigen 96 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23643|23643]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y6Y9|Q9Y6Y9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LY96&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LY96|Open PubMed]] * **OMIM**: [[https://omim.org/entry/605243|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Binds bacterial lipopolysaccharide (LPS) (PubMed:17803912, PubMed:17569869). Cooperates with TLR4 in the innate immune response to bacterial lipopolysaccharide (LPS), and with TLR2 in the response to cell wall components from Gram- positive and Gram-negative bacteria (PubMed:11160242, PubMed:11593030). Enhances TLR4-dependent activation of NF-kappa-B (PubMed:10359581). Cells expressing both LY96 and TLR4, but not TLR4 alone, respond to LPS (PubMed:10359581). {ECO:0000269|PubMed:10359581, ECO:0000269|PubMed:11160242, ECO:0000269|PubMed:11593030, ECO:0000269|PubMed:17569869, ECO:0000269|PubMed:17803912}. |E1 DerP2 DerF2| |detection of lipopolysaccharide| |lipopolysaccharide receptor complex| |lipopolysaccharide receptor activity| |Toll-like receptor 4 binding| |negative regulation of MyD88-independent toll-like receptor signaling pathway| |regulation of MyD88-independent toll-like receptor signaling pathway| |positive regulation of lipopolysaccharide-mediated signaling pathway| |detection of molecule of bacterial origin| |toll-like receptor 4 signaling pathway| |detection of external biotic stimulus| |detection of biotic stimulus| |necroptotic process| |regulation of lipopolysaccharide-mediated signaling pathway| |programmed necrotic cell death| |TRIF-dependent toll-like receptor signaling pathway| |necrotic cell death| |MyD88-independent toll-like receptor signaling pathway| |MyD88-dependent toll-like receptor signaling pathway| |lipopolysaccharide-mediated signaling pathway| |coreceptor activity| |lipopolysaccharide binding| |intrinsic component of plasma membrane| |negative regulation of toll-like receptor signaling pathway| |cellular defense response| |regulation of toll-like receptor signaling pathway| |I-kappaB kinase/NF-kappaB signaling| |positive regulation of tumor necrosis factor production| |positive regulation of tumor necrosis factor superfamily cytokine production| |toll-like receptor signaling pathway| |pattern recognition receptor signaling pathway| |regulation of tumor necrosis factor production| |regulation of tumor necrosis factor superfamily cytokine production| |cellular response to lipopolysaccharide| |cellular response to molecule of bacterial origin| |endosome membrane| |cellular response to biotic stimulus| |innate immune response-activating signal transduction| |activation of innate immune response| |apoptotic signaling pathway| |response to lipopolysaccharide| |response to molecule of bacterial origin| |positive regulation of innate immune response| |positive regulation of response to biotic stimulus| |negative regulation of immune system process| |positive regulation of cytokine production| |regulation of innate immune response| |positive regulation of defense response| |inflammatory response| |positive regulation of multi-organism process| |cellular response to lipid| |regulation of response to biotic stimulus| |detection of chemical stimulus| |immune response-activating signal transduction| |immune response-regulating signaling pathway| |positive regulation of response to external stimulus| |activation of immune response| |detection of stimulus| |response to bacterium| |regulation of cytokine production| |regulation of defense response| |innate immune response| |regulation of multi-organism process| |response to lipid| |positive regulation of immune response| |apoptotic process| |defense response to other organism| |programmed cell death| |cellular response to oxygen-containing compound| |cell death| |regulation of response to external stimulus| |regulation of immune response| |positive regulation of immune system process| |negative regulation of signal transduction| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |negative regulation of cell communication| |negative regulation of signaling| |regulation of response to stress| |response to oxygen-containing compound| |extracellular space| |negative regulation of response to stimulus| |positive regulation of signal transduction| |regulation of immune system process| |intracellular signal transduction| |positive regulation of multicellular organismal process| |positive regulation of cell communication| |positive regulation of signaling| |immune response| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp462|Cadmium 60μM R08 exp462]]|-2.34| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-1.85| |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|-1.83| |[[:results:exp341|BRD2 inhibitor II 20μM R07 exp341]]|1.71| |[[:results:exp399|Salubrinal 20μM R07 exp399]]|1.75| |[[:results:exp461|BS-181 20μM R08 exp461]]|1.86| |[[:results:exp69|Deguelin 0.05μM R02 exp69]]|1.88| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|1.91| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 18999 * **Expression level (log2 read counts)**: 0.8 {{:chemogenomics:nalm6 dist.png?nolink |}}